Novartis And BioAge Team Up To Develop Aging Therapies And Boost Investor Potential

BioAge Labs (NASDAQ: BIOA ) is a biopharmaceutical company focused on the development of new therapies for metabolic diseases by harnessing the biology of human aging. The company was founded in 2015, and it became public in SeptemberOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineerings, and +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs including orthopaedics and rare diseases. As an investor, I have been utilising my ...